Israel’s Chief Epidemiologist Visits VRC
Image
Chief Epidemiologist for Israel Dr. Sharon Alroy-Preis (l) listens with Dr. Daniel Douek (c), chief of the VRC human immunology section, as Dr. Robert Seder, chief of the center’s cellular immunology section, provides an overview of the VRC’s development of monoclonal antibodies to prevent malaria.
Photo: Chia-Chi Charlie Chang
Image
Involved in the visit are (from l) Abe Mittelman, VRC senior advisor; Dr. Christina Harris, VRC deputy associate director for management and operations; Dr. Jennifer Anderson, VRC associate director for management and operations; Alroy-Preis; Pierson; Douek; Dr. Karin Bok, VRC acting deputy director; Seder; and Dr. Masaru Kanekiyo, chief of the VRC molecular immunoengineering section.
Photo: Chia-Chi Charlie Chang
Image
VRC Director Dr. Ted Pierson and Alroy-Preis chat.
Photo: Chia-Chi Charlie Chang
The National Institute of Allergy and Infectious Diseases’s (NIAID) Vaccine Research Center (VRC) hosted Dr. Sharon Alroy-Preis, head of the Public Health Directorate at the Israeli Ministry of Health and chief epidemiologist for Israel on Apr. 3.
During the visit, Alroy-Preis received an overview of the VRC’s research activities involving development of mucosal vaccines to prevent Covid and development of monoclonal antibodies for prevention of malaria.